rs1041885

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019111.5(HLA-DRA):​c.*392T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 152,962 control chromosomes in the GnomAD database, including 1,879 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 1869 hom., cov: 28)
Exomes 𝑓: 0.088 ( 10 hom. )

Consequence

HLA-DRA
NM_019111.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.41

Publications

31 publications found
Variant links:
Genes affected
HLA-DRA (HGNC:4947): (major histocompatibility complex, class II, DR alpha) HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. This molecule is expressed on the surface of various antigen presenting cells such as B lymphocytes, dendritic cells, and monocytes/macrophages, and plays a central role in the immune system and response by presenting peptides derived from extracellular proteins, in particular, pathogen-derived peptides to T cells. The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.176 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_019111.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-DRA
NM_019111.5
MANE Select
c.*392T>A
3_prime_UTR
Exon 5 of 5NP_061984.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-DRA
ENST00000395388.7
TSL:6 MANE Select
c.*392T>A
3_prime_UTR
Exon 5 of 5ENSP00000378786.2
HLA-DRA
ENST00000374982.5
TSL:6
c.*392T>A
3_prime_UTR
Exon 5 of 5ENSP00000364121.5
ENSG00000299747
ENST00000766007.1
n.163-6772A>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.152
AC:
22870
AN:
150820
Hom.:
1872
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.114
Gnomad AMR
AF:
0.125
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.125
Gnomad SAS
AF:
0.0674
Gnomad FIN
AF:
0.206
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.179
Gnomad OTH
AF:
0.147
GnomAD4 exome
AF:
0.0879
AC:
178
AN:
2024
Hom.:
10
Cov.:
0
AF XY:
0.0935
AC XY:
95
AN XY:
1016
show subpopulations
African (AFR)
AF:
0.0909
AC:
6
AN:
66
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.0233
AC:
2
AN:
86
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
0.0892
AC:
144
AN:
1614
European-Non Finnish (NFE)
AF:
0.189
AC:
14
AN:
74
Other (OTH)
AF:
0.0667
AC:
12
AN:
180
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.152
AC:
22876
AN:
150938
Hom.:
1869
Cov.:
28
AF XY:
0.149
AC XY:
10966
AN XY:
73626
show subpopulations
African (AFR)
AF:
0.121
AC:
4983
AN:
41018
American (AMR)
AF:
0.124
AC:
1889
AN:
15180
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
358
AN:
3460
East Asian (EAS)
AF:
0.125
AC:
640
AN:
5122
South Asian (SAS)
AF:
0.0664
AC:
316
AN:
4762
European-Finnish (FIN)
AF:
0.206
AC:
2115
AN:
10288
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.179
AC:
12144
AN:
67804
Other (OTH)
AF:
0.147
AC:
308
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
946
1891
2837
3782
4728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.172
Hom.:
1358
Bravo
AF:
0.146
Asia WGS
AF:
0.0890
AC:
311
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
8.7
DANN
Benign
0.52
PhyloP100
2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1041885; hg19: chr6-32412809; API